NAB1 Antibodies

Santa Cruz Biotechnology provides a broad selection of NAB1 Antibodies for research focused on understanding NAB1's role in various biological processes. NAB1 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). NAB1, or NGFI-A-binding protein 1, functions as a critical regulator of gene expression and plays a significant role in cellular responses to growth factors and stress. NAB1 actively participates in the modulation of transcriptional activity and has been linked to various physiological and pathological processes, including cancer progression and neuronal function. Understanding NAB1's molecular mechanisms and interactions provides valuable insights into cellular regulation and disease development. Researchers worldwide rely on NAB1 monoclonal antibodies to advance their investigations in cancer biology, neuroscience, and cellular signaling pathways. NAB1 monoclonal antibodies enable reproducible experimental results across different research applications. Santa Cruz Biotechnology monoclonal antibodies for NAB1 continue to support breakthrough discoveries in cell biology and disease research.